Kore Private Wealth’s Asterias Biotherapeutics Inc. Series A AST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-208
Closed 1030
2018
Q4
$0 Buy
+208
New +$216 ﹤0.01% 869

Kore Private Wealth's AST Position: Q1 2019 in Review

Kore Private Wealth sold out of Asterias Biotherapeutics Inc. Series A (AST) in Q1 2019, closing a stake of 208 shares.

Kore Private Wealth first reported a position in AST in Q4 2018 and held it in 1 quarter. The position peaked at $0 in Q4 2018. 0 funds tracked by Wall St. Rank hold AST as of Q1 2019.

  • Kore Private Wealth reported no remaining Asterias Biotherapeutics Inc. Series A position as of Q1 2019 after selling out during the quarter.
  • Kore Private Wealth sold 208 Asterias Biotherapeutics Inc. Series A shares in Q1 2019.
  • Kore Private Wealth first reported a position in Asterias Biotherapeutics Inc. Series A in Q4 2018 and held it in 1 quarter.
  • Kore Private Wealth's Asterias Biotherapeutics Inc. Series A position peaked at $0 in Q4 2018.
  • 0 funds tracked by Wall St. Rank held Asterias Biotherapeutics Inc. Series A as of Q1 2019.

Based on Kore Private Wealth's 13F filing for Q1 2019, filed 16 May 2019.